C-reactive protein as a predictor of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) cohort

Journal of Human Hypertension

Volumn 26, Issue 2, 2012, Pages 108-116

  Cheung, B M Y ^a   Ong, K L ^a   Tso, A W K ^a   Leung, R Y H ^a   Xu, A ^a   Cherny, S S ^a,b   Sham, P C ^a,b   Lam, T H ^a   Lam, K S L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

C reactive protein; gene; single nucleotide polymorphism

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; FEMALE; GENETIC VARIABILITY; GENOTYPE; HONG KONG; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HONG KONG; HUMANS; HYPERTENSION; INFLAMMATION; INFLAMMATION MEDIATORS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION;

EID: 84855860049     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.125     Document Type: Article

References (41)

1. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. NEngl J Med 2000; 342: 836-843. (Pubitemid 30165206)
2. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-1565. (Pubitemid 35315836)
3. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003; 107: 391-397.
4. Bautista LE, López-Jaramillo P, Vera LM, Casas JP, Otero AP, Guaracao AI. Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 2001; 19: 857-861. (Pubitemid 32436948)
5. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of develop-ing hypertension. JAMA 2003; 290: 2945-2951. (Pubitemid 37505526)
6. Dauphinot V, Roche F, Kossovsky MP, Schott AM, Pichot V, Gaspoz JM et al. C-reactive protein implica-tions in new-onset hypertension in a healthy popula-tion initially aged 65 years: the Proof study. J Hypertens 2009; 27: 736-743.
7. Davey Smith G, Lawlor DA, Harbord R, Timpson N, Rumley A, Lowe GD et al. Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol 2005; 25: 1051-1056. (Pubitemid 40627854)
8. Lakoski SG, Herrington DM, Siscovick DM, Hulley SB. C-reactive protein concentration and incident hyper-tension in young adults: the CARDIA study. Arch Intern Med 2006; 166: 345-349. (Pubitemid 43244323)
9. Carlson CS, Aldred SF, Lee PK, Tracy RP, Schwartz SM, Rieder M et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 2005; 77: 64-77. (Pubitemid 40848037)
10. Kathiresan S, Larson MG, Vasan RS, Guo CY, Gona P, Keaney Jr JF et al. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006; 113: 1415-1423. (Pubitemid 43739438)
11. Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, Durda JP et al. Association of polymorph-isms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006; 296: 2703-2711. (Pubitemid 44917547)
12. Wang Q, Hunt SC, Xu Q, Chen YE, Province MA, Eckfeldt JH et al. Association study of CRP gene polymorphisms with serum CRP level and cardiovas-cular risk in the NHLBI Family Heart Study. Am J Physiol Heart Circ Physiol 2006; 291: H2752-H2757. (Pubitemid 44904075)
13. Lee CC, You NC, Song Y, Hsu YH, Manson J, Nathan L et al. Relation of genetic variation in the gene coding for C-reactive protein with its plasma protein concen-trations: findings from the Women's Health Initiative Observational cohort. Clin Chem 2009; 55: 351-360.
14. Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, Matthews KA, Johnston J, Sowers MR et al. Ethnic differences in C-reactive protein concentrations. Clin Chem 2008; 54: 1027-1037. (Pubitemid 351793410)
15. Cheung BM, Thomas GN. The metabolic syndrome and vascular disease in Asia. Cardiovasc Hematol Disord Drug Targets 2007; 7: 79-85. (Pubitemid 47024124)
16. Dwivedi G, Beevers DG. Hypertension in ethnic groups: epidemiological and clinical perspectives. Expert Rev Cardiovasc Ther 2009; 7: 955-963.
17. Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, Leung GM et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care 2007; 30: 1430-1436. (Pubitemid 46871150)
18. Cheung BM, Wat NM, Man YB, Tam S, Cheng CH, Leung GM et al. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2). AmJ Hypertens 2008; 21: 17-22.
19. Cheung BM, Wat NM, Tso AW, Tam S, Thomas GN, Leung GM et al. Raised blood pressure and dysglyce-mia in Hong Kong Chinese. Diabetes Care 2008; 31: 1889-1891.
20. Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, Fong CH et al. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation 2007; 115: 1537-1543. (Pubitemid 46648638)
21. Lui MM, Lam JC, Mak HK, Xu A, Ooi C, Lam DC et al. C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest 2009; 135: 950-956.
22. International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437: 1299-1320.
23. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769. (Pubitemid 38420107)
24. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029)
25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)
26. Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension 2003; 41: 207-210. (Pubitemid 36204890)
27. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto Jr AM, Kastelein JJ et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.
28. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto Jr AM, Kastelein JJ et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009; 373: 1175-1182.
29. Hak AE, Stehouwer CD, Bots ML, Polderman KH, Schalkwijk CG, Westendorp IC et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 1999; 19: 1986-1991. (Pubitemid 29379933)
30. Davey Smith G, Ebrahim S. 'Mendelian randomiza-tion': can genetic epidemiology contribute to under-standing environmental determinants of disease? Int J Epidemiol 2003; 32: 1-22. (Pubitemid 36503465)
31. Lawlor DA, Harbord RM, Timpson NJ, Lowe GD, Rumley A, Gaunt TR et al. The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4610 cases amongst 18 637 participants. PLoS One 2008; 3: e3011.
32. Schumacher W, Cockcroft J, Timpson NJ, McEniery CM, Gallacher J, Rumley A et al. Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Hypertension 2009; 53: 150-157.
33. Komurcu-Bayrak E, Erginel-Unaltuna N, Onat A, Ozsait B, Eklund C, Hurme M et al. Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults. Atherosclerosis 2009; 206: 474-479.
34. Brunner EJ, Kivimäki M, Witte DR, Lawlor DA, Davey Smith G, Cooper JA et al. Inflammation, insulin resistance, and diabetes\-Mendelian randomization using CRP haplotypes points upstream. PLoS Med 2008; 5: e155.
35. Timpson NJ, Lawlor DA, Harbord RM, Gaunt TR, Day IN, Palmer LJ et al. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 2005; 366: 1954-1959. (Pubitemid 41713985)
36. Kivimäki M, Lawlor DA, Smith GD, Kumari M, Donald A, Britton A et al. Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study. PLoS One 2008; 3: e3013.
37. Kivimäki M, Lawlor DA, Eklund C, Smith GD, Hurme M, Lehtimäki T et al. Mendelian randomization suggests no causal association between C-reactive protein and carotid intima-media thickness in the young Finns study. Arterioscler Thromb Vasc Biol 2007; 27: 978-979. (Pubitemid 46606735)
38. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387-1397. (Pubitemid 38419992)
39. Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med 2006; 166: 1368-1373. (Pubitemid 44036348)
40. Cheung BM. The cardiovascular continuum in Asia\-a new paradigm for the metabolic syndrome. J Cardio-vasc Pharmacol 2005; 46: 125-129. (Pubitemid 41060203)
41. Purcell S, Cherny SS, Sham PC Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149-150. (Pubitemid 36150192)